Formulated Solutions
Quick Facts: Formulated Solutions
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Largo, Florida, United States
- Website
- https://www.formulatedsolutions.com/
- Modalities
- Topicals, Inhalation & Nasal, Finished Dosage Forms, Oral Liquids, Semi-solids & Liquids
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Formulated Solutions
Formulated Solutions is a contract development and manufacturing organization (CDMO). Capabilities: Topicals, Inhalation & Nasal, Finished Dosage Forms, Oral Liquids, Semi-solids & Liquids. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.formulatedsolutions.com/
Signal Score
Formulated Solutions FDA Inspection History
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-04-04 |
Formulated Solutions, LLC
Largo, Florida
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2024-04-12 |
Formulated Solutions Cleveland LLC
Cleveland, Tennessee
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Formulated Solutions FDA 483 Findings 3 observations · 2024-04-12 → 2025-04-04 ?
By subsystem
By severity
- 3 — Moderate: 1
- 2 — Minor: 2
- Repeat observations: 0
Most severe findings
-
Scientifically sound laboratory controls
"Laboratory controls do not include the establishment of scientifically sound and appropriate specifications designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity."
-
Procedures not in writing, fully followed
"The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed."
-
Cleaning / Sanitizing / Maintenance
"Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product."